pukkamex (PUX)

Revnue sharing crypto-derivative trading platform

Review Score
4.65/5
ICO Price
0.05 USD
Pre ICO Price
0.04 USD
Soft Cap
1,500,000 USD
Hard Cap
3,750,000 USD
Pre ICO Start Date
1 April 2019
Pre ICO End Date
15 June 2019
Start Date
1 July 2019
End Date
30 July 2019

What is pukkamex?

 

pukkamex is a crypto trading platform offering leverage up to 100x. pukkamex is Easy to use for the beginner and powerful enough for the most experienced trader. We offer unique, never before seen features. pukkamex does everything our competitors do, we just do it bigger, faster and better. Our competitive features blow all other trading platforms right out of the water.

With our copy trading platform you can copy top traders from the leader board in return for a percentage share of the profit you made; the platform does everything for you, all you have to do is follow your favorite trader.

We support multiple languages including Arabic and English and offer a wide range of derivatives; whether you are day trading, investing or hedging you will find the best tools to compliment your trading strategy.

Revenue Sharing; 25% of gross revenue is distributed to PUX holders every Sunday at 12:00 GMT via smart contract. Earn money by simply moving your trading account to pukkamex and purchasing PUX tokens.

Information displayed on CoinCheckup can be updated by the respective ICOs and/or Crypto representatives and does not present the opinion of CoinCheckup.com and/or the CoinCheckup team.

Trading and investing in digital assets is highly speculative and comes with many risks. The analysis/stats on CoinCheckup.com and it’s subsites are for informational purposes and should not be considered investment advice and or the truth. Statements and financial information on CoinCheckup.com and it’s subsites should not be construed as an endorsement or recommendation to buy, sell or hold.

Please do your own research on all of your investments carefully. Scores are based on averages of third party websites.  Past performance is no indicative of future results. Read the full disclaimer here.